Compare CRBU & UTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | UTMD |
|---|---|---|
| Founded | 2011 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 177.4M |
| IPO Year | 2021 | N/A |
| Metric | CRBU | UTMD |
|---|---|---|
| Price | $1.91 | $56.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 13.4K |
| Earning Date | 11-12-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.54 |
| Revenue | $9,295,000.00 | ★ $38,633,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | ★ N/A | $15.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $51.26 |
| 52 Week High | $3.54 | $65.56 |
| Indicator | CRBU | UTMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 47.37 |
| Support Level | $1.75 | $54.60 |
| Resistance Level | $1.97 | $56.26 |
| Average True Range (ATR) | 0.12 | 1.22 |
| MACD | 0.02 | 0.28 |
| Stochastic Oscillator | 66.20 | 78.43 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.